Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
3/28/2025
DualityBio Advances Toward Hong Kong Stock Exchange Listing
3/28/2025
Chinese Scientists Develop Breakthrough Vaccine Molecule to Enhance Im...
3/28/2025
GenFleet Thera Reports Promising Phase II Results for Fulzerasib and C...
3/28/2025
Shanton Reveals Topline Data from Phase 2b Study in Refractory Gout Pa...
3/28/2025
AstraZeneca Advances AZD0120 CAR-T Trial for Lupus
3/28/2025
NiKang Thera Completes Dosing of the First Cohort in a Phase 1 Study ...
3/28/2025
TaiMed Announces Results from Phase 2a Data on Long-Acting HIV Mainten...
3/28/2025
Recent Executive Moves
3/28/2025
China Releases Draft Implementation Measures for the Protection of Dru...
3/27/2025
Big Pharma Faces Headwinds in China as Vaccine Sales Decline (PT)
3/27/2025
China to Spur Innovation through New Reimbursement List (ThePharmaLett...
3/27/2025
China Poised to Surpass Europe in Pharma Innovation, Says AZ CEO
3/27/2025
China Faces Ongoing TB Prevention Challenges Despite Declining Inciden...
3/27/2025
NMPA Approves Suraxavir Marboxil for Influenza Treatment
3/26/2025
Merck Licenses Hengrui's Investigational Lp(a) Inhibitor HRS-5346
3/26/2025
Ractigen's RAG-01 Shows Promising Early Complete Responses in Phase I ...
3/26/2025
NMPA Holds 2025 National Drug Regulatory Policy and Law Conference
3/26/2025
NMPA Issues Announcement on the Implementation of Chinese Pharmacopoei...
3/26/2025
Bayer Secures Global Rights to Puhe BioPharma's Experimental Cancer Dr...
3/26/2025
Life Science Ecosystems in Asia: Biomedical Innovation Trends over the...
3/25/2025
Anda Biopharma Secures Series A Funding to Advance PCNAT-01 Clinical S...
3/25/2025
Novo Nordisk and the United Labs Announce License Deal for UBT251
3/25/2025
BrightGene Initiates Phase II Head-to-Head Study of AI-Designed BGM050...
3/25/2025
Everest Announces FDA Clearance of IND Application for Tumor-Associate...
3/25/2025
Eli Lilly Launches Lilly Gateway Laboratory in Beijing to Foster Innov...
3/25/2025
Merck Group to Expand in China with Focus on AI-Powered Precision Medi...
3/25/2025
China's BMI Fund Surpasses CNY16.5 Trillion with 11% Annual Growth
3/25/2025
Expedition Therapeutics Secures Seed Funding to Bridge Chinese Innovat...
3/25/2025
Growing Awareness and Expanding Treatment Options for Sleep Disorders ...
3/25/2025
Hengrui and Elevar Face Second FDA Rejection for Liver Cancer Combo Th...
Page:
4
/
761
Total number of articles:
22823
:
[First]
[<<]
[2]
[3]
[4]
[5]
[6]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit